There is a persistent gap in the application of knowledge gained from basic science studies to clinical neuroscience research models related to alcoholism. A new generation of psychopharmacology, neuroimaging, and molecular genetic studies rooted in molecular neuroscience has broad clinical implications and these studies bring the potential to bridge the gap between basic and clinical research. Despite the quality of the available science, progress in actually bridging this gap depends also upon the availability of appropriately trained young scientists. The purpose of this training program is to meet this need by providing post-doctoral training for a total of 3 physicians or PhDs interested in careers in translational research in the field of alcoholism. The proposed training program is a two-year program in the Department of Psychiatry, Yale University School of Medicine, and will afford post-doctoral trainees the opportunity to devote virtually full-time effort during the initial phase of their careers to developing the skills and experience needed to become independent researchers in the field of translational research in alcoholism. Within this program, there are four Core Programs, the Clinical Core, the Neuroimaging Core, the Genetics Core and the Basic Science Core. The program faculty are affiliated with two center grants (the NIAAA-funded Center for the Translational Neuroscience of Alcoholism and the VA-funded VA Alcohol Research Center), both of which are multi-disciplinary and enable the group to conduct research that moves rapidly and in both directions from preclinical projects (""""""""bench"""""""") to clinical studies (""""""""bedside"""""""" and """"""""community""""""""). Applicants will be MD's or PhD post-doctoral candidates trained in specialties that include psychiatry, internal medicine, clinical psychology or neuroscience. Candidates will be selected by an admission committee based on their potential for excellence in the field of translational research in alcoholism. Three applicants will be selected annually for the Core Components: two for the clinically-oriented core programs (Clinical or Neuroimaging) and one for the Basic Science or Genetics core. The program includes (1) individualized research preceptorship, (2) successful completion of a translational-research project, (3) a core curriculum, which include seminars on substance abuse clinical research and treatment, biostatistics and research design, the responsible conduct of scientific research and grant writing skills and (4) individualized participation in seminars of interest in the Department, Medical School and University, (5) clinical training and (6) training for teaching. The training facilities include the major institutions affiliated with Yale School of Medicine, Department of Psychiatry. At the conclusion of training, applicants will be well suited for independent careers in translational research in the field of alcoholism. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Institutional National Research Service Award (T32)
Project #
5T32AA015496-04
Application #
7458744
Study Section
Special Emphasis Panel (ZAA1-HH (01))
Program Officer
Matochik, John A
Project Start
2005-07-01
Project End
2010-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
4
Fiscal Year
2008
Total Cost
$123,963
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
DeMartini, Kelly S; Schilsky, Michael L; Palmer, Amanda et al. (2018) Text Messaging to Reduce Alcohol Relapse in Prelisting Liver Transplant Candidates: A Pilot Feasibility Study. Alcohol Clin Exp Res 42:761-769
Roberts, Walter; Shi, Julia M; Tetrault, Jeanette M et al. (2018) Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study. J Addict Med 12:227-233
Roberts, Walter; Harrison, Emily L R; McKee, Sherry A (2017) Effects of varenicline on alcohol cue reactivity in heavy drinkers. Psychopharmacology (Berl) 234:2737-2745
Fucito, Lisa M; DeMartini, Kelly S; Hanrahan, Tess H et al. (2017) Using Sleep Interventions to Engage and Treat Heavy-Drinking College Students: A Randomized Pilot Study. Alcohol Clin Exp Res 41:798-809
Verplaetse, Terril L; Pittman, Brian P; Shi, Julia M et al. (2016) Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings. Alcohol Clin Exp Res 40:1567-76
Verplaetse, Terril L; Pittman, Brian P; Shi, Julia M et al. (2016) Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders. J Addict Med 10:166-73
Yip, Sarah W; DeVito, Elise E; Kober, Hedy et al. (2016) Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response. Drug Alcohol Depend 166:134-42
Morean, Meghan E; Kong, Grace; Camenga, Deepa R et al. (2016) Latent class analysis of current e-cigarette and other substance use in high school students. Drug Alcohol Depend 161:292-7
Banz, Barbara C; Yip, Sarah W; Yau, Yvonne H C et al. (2016) Behavioral addictions in addiction medicine: from mechanisms to practical considerations. Prog Brain Res 223:311-28
Worhunsky, Patrick D; Dager, Alecia D; Meda, Shashwath A et al. (2016) A Preliminary Prospective Study of an Escalation in 'Maximum Daily Drinks', Fronto-Parietal Circuitry and Impulsivity-Related Domains in Young Adult Drinkers. Neuropsychopharmacology 41:1637-47

Showing the most recent 10 out of 58 publications